Implants and Pellets

Implants and pellets are solid dosage forms placed under the skin or into body tissues to provide controlled release of medication over extended periods, ranging from weeks to years. These formulations eliminate the need for frequent dosing, improve patient adherence, and maintain steady drug concentrations without the fluctuations associated with intermittent dosing. Implantable drug delivery is used for contraception, hormone replacement, cancer therapy, and chronic pain management.

What Are Implants and Pellets?

An implant is a sterile, solid device containing a drug that is surgically or procedurally placed into subcutaneous tissue or a body cavity. The implant releases drug at a controlled rate determined by its composition, geometry, and the properties of the surrounding tissue. Implants can be made from biocompatible polymers that degrade over time or from nondegradable materials that must be removed after the drug is depleted. Pellets are small, compressed cylinders of drug that are implanted subcutaneously, typically for hormone replacement therapy.

Types of Implants and Pellets

Contraceptive implants such as etonogestrel implants consist of a flexible polymer rod that releases progestin at a steady rate for up to three years. The implant is inserted subcutaneously in the upper arm and provides highly effective, reversible contraception. It is one of the most effective contraceptive methods available, with a failure rate comparable to sterilization.

Drug-eluting implants used in oncology slowly release chemotherapeutic agents directly into or near tumors. These implants maximize local drug concentrations while minimizing systemic exposure. Gliadel wafers, for example, are implanted into the resection cavity after brain tumor surgery and release carmustine locally over several weeks. Biodegradable implants are made from polymers such as polylactic-co-glycolic acid that hydrolyze in the body into biocompatible byproducts, eliminating the need for removal.

Testosterone pellets are small, fused cylinders of crystalline testosterone that are implanted subcutaneously for testosterone replacement therapy. Each pellet releases testosterone over three to six months. The pellets are inserted through a small skin incision using a specialized trocar.

When to Use

Implants are indicated when long-term, continuous drug delivery is required and when patient adherence to daily medication is a concern. They are particularly valuable for contraception, where perfect adherence to daily oral contraceptives is challenging. Implants are also used for chronic conditions requiring stable drug levels, such as pain management with opioid implants or hormone therapy with testosterone or estradiol implants. Local drug delivery to tumors or surgical sites is another important application.

When Not to Use

Implants are not appropriate for acute conditions requiring rapid dose adjustment or short-term therapy. The surgical or procedural placement requires trained personnel and sterile technique. Implants cannot be easily removed if adverse effects occur, particularly nondegradable implants that require a removal procedure. Patients with active infections at the implantation site, bleeding disorders, or allergies to implant materials are not suitable candidates.

Advantages

Practical Benefits

Extended dosing intervals from months to years improve adherence
Elimination of daily medication management
Steady drug concentrations without peaks and troughs
Reduced clinic visits for medication administration

Clinical Benefits

Consistent therapeutic drug levels over the entire dosing period
Avoidance of first-pass metabolism and gastrointestinal absorption variability
Lower total drug dose compared to repeated daily dosing
Reduced systemic side effects with local implants
Reversible contraception with prompt return to fertility after removal

Disadvantages

Clinical Limitations

Minor surgical procedure required for insertion and removal
Risk of insertion site infection, hematoma, or scarring
Difficulty removing if adverse drug reactions occur
Limited ability to adjust dose after implantation

Visible or palpable implant may cause cosmetic concern
Procedural pain or anxiety associated with insertion
Requires visit to healthcare provider for both insertion and removal
Foreign body sensation and potential for migration

Best Practices for Administration

Implants should be inserted under aseptic conditions by trained healthcare professionals following the manufacturer’s instructions. The insertion site should be cleaned and anesthetized before the procedure. The implant should be placed at the correct depth in subcutaneous tissue to ensure proper drug release and facilitate later removal. Patients should be educated about what to expect, including the insertion procedure, potential side effects, and the importance of timely removal. A written record of the implant location, type, and insertion date should be maintained.

Special Considerations

Nondegradable implants must be removed after the drug is depleted, and patients should be reminded of the removal date. Implants that are not removed may continue to release drug at declining rates or may become fibrotic and difficult to remove. Biodegradable implants do not require removal, but the degradation products must be biocompatible and nontoxic. Palpable implants should be located during routine physical examination to confirm they remain in place. Some implants are radiopaque and visible on X-ray if migration is suspected.

Conclusion

Implants and pellets provide a highly effective approach to long-term drug delivery with excellent adherence and stable pharmacokinetics. The requirement for procedural placement and removal, along with the limited ability to adjust dosing, makes patient selection and counseling particularly important. Advances in biodegradable polymers and implant design continue to expand the applications of this delivery technology.